Online citations, reference lists, and bibliographies.
← Back to Search

Problems In Mesothelioma Diagnosis

Bruce Addis, Heather Roche
Published 2009 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Many centres are now seeing increasing numbers of patients with malignant mesothelioma. This presents pathologists involved in making the diagnosis with a number of problems, which can be divided into those encountered in making the distinction between mesothelioma and benign changes and those experienced in separating mesotheliomas from other types of epithelial and connective tissue tumours. Immunohistochemistry plays a major role in helping to make the diagnosis, but it should be interpreted with due regard to the clinical setting and radiological features, and with a knowledge of the wide morphological variations seen in mesothelioma. This review identifies some of these problems and addresses the uses and limitations of immunohistochemistry in different situations. It includes a discussion of some of the less common variants of mesothelioma and other pleural‐based tumours that enter into the differential diagnosis.
This paper references
10.1016/0169-5002(95)90216-3
Malignancies in the lung and pleura mimicking benign processes.
T. Colby (1995)
10.1097/00000478-200006000-00006
Epithelial mesothelioma with deciduoid features: report of four cases.
N. Ordóñez (2000)
Primary pleuropulmonary synovial sarcoma: reappraisal of a recently described anatomic subset
LR Essary (2002)
10.1097/00000478-199612000-00001
Malignant vascular tumors of the serous membranes mimicking mesothelioma. A report of 14 cases.
B. T. Lin (1996)
10.1111/j.1365-2559.1992.tb00915.x
The histology and immunohistochemistry of small cell mesothelioma
F. Mayall (1992)
10.1093/AJCP/110.2.191
The diagnosis of desmoplastic malignant mesothelioma and its distinction from fibrous pleurisy: a histologic and immunohistochemical analysis of 31 cases including p53 immunostaining.
W. E. Mangano (1998)
10.1043/1543-2165(2005)129[1415:ROHPOD]2.0.CO;2
Recognition of histopathologic patterns of diffuse malignant mesothelioma in differential diagnosis of pleural biopsies.
T. Allen (2005)
10.1093/RHEUMATOLOGY/KEG428
A fatal case of pleural osteosarcoma mimicking mesothelioma in Paget's disease of bone.
K. Chakravarty (2003)
10.1136/jcp.48.9.856
Malignant mesothelioma of the pleura: interobserver variability.
A. Andrion (1995)
10.1046/j.1365-2559.2001.01295.x
Malignant epithelioid mesothelioma: anti‐mesothelial marker expression correlates with histological pattern
R. Attanoos (2001)
10.1016/J.HUMPATH.2006.08.010
What are the current best immunohistochemical markers for the diagnosis of epithelioid mesothelioma? A review and update.
N. Ordóñez (2007)
10.1097/00000478-200203000-00011
Expression of Telomerase Reverse Transcriptase (TERT) in Malignant Mesotheliomas
F. Kumaki (2002)
10.1043/0003-9985(2001)125<1588:UCCVOE>2.0.CO;2
Unusual clear cell variant of epithelioid mesothelioma.
E. Dessy (2001)
10.1016/J.CCM.2006.01.006
Pathology of the pleura.
J. English (2006)
10.1097/PAS.0b013e31802baad7
Lymphohistiocytoid Variant of Malignant Mesothelioma of the Pleura: A Series of 22 Cases
F. Galateau-Sallé (2007)
10.3109/01913129609016333
Clear cell mesothelioma.
N. Ordóñez (1996)
Detection of SS18SSX fusion transcripts in formalin-fixed paraffin-embedded neoplasms: analysis of conventional RT-PCR, qRT-PCR and dual color FISH as diagnostic tools for synovial sarcomas
MF Amary (2007)
10.1080/019131290505176
Lymphohistiocytoid Mesothelioma: A Clinical, Immunohistochemical and Ultrastructural Study of Four Cases and Literature Review
D. Yao (2004)
10.1093/OCCMED/KQI034
Mesothelioma mortality in Great Britain from 1968 to 2001.
D. McElvenny (2005)
10.1007/s11748-007-0216-5
Extraskeletal osteosarcoma of the pleura: a case report
R. Matono (2008)
10.1053/J.SEMDP.2006.06.002
Spindle cell tumors of the pleura: differential diagnosis.
M. Rdzanek (2006)
10.1097/PAS.0b013e31814faacf
Podoplanin is a Better Immunohistochemical Marker for Sarcomatoid Mesothelioma Than Calretinin
Diana M Padgett (2008)
Deciduoid mesthelioma: a report of 5 cases and literature review
J Shia (2002)
Mucinpositive mesotheliomas: a histochemical, immunohistochemical, and ultrastructural comparison with mucin-secreting pulmonary adenocarcinomas
SP Hammar (1996)
10.1093/AJCP/110.3.397
Reactive mesothelial hyperplasia vs mesothelioma, including mesothelioma in situ: a brief review.
D. Henderson (1998)
10.1043/1543-2165(2005)129[1407:IDOEMA]2.0.CO;2
Immunohistochemical diagnosis of epithelioid mesothelioma: an update.
N. Ordóñez (2005)
10.1002/DC.20747
Utility of WT‐1, p63, MOC31, mesothelin, and cytokeratin (K903 and CK5/6) immunostains in differentiating adenocarcinoma, squamous cell carcinoma, and malignant mesothelioma in effusions
Robert T. Pu (2008)
10.1043/1543-2165(2005)129[1421:DDOBAM]2.0.CO;2
Differential diagnosis of benign and malignant mesothelial proliferations on pleural biopsies.
P. Cagle (2005)
10.1097/00000478-200302000-00002
Expression of Calretinin, Thrombomodulin, Keratin 5, and Mesothelin in Lung Carcinomas of Different Types: An Immunohistochemical Analysis of 596 Tumors in Comparison With Epithelioid Mesotheliomas of the Pleura
M. Miettinen (2003)
10.1016/J.HUMPATH.2003.11.013
The diagnostic utility of immunohistochemistry in distinguishing between mesothelioma and renal cell carcinoma: a comparative study.
N. Ordóñez (2004)
10.1002/(SICI)1096-9896(199910)189:2<251::AID-PATH412>3.0.CO;2-F
The use of histological and immunohistochemical markers to distinguish pleural malignant mesothelioma and in situ mesothelioma from reactive mesothelial hyperplasia and reactive pleural fibrosis
P. Cury (1999)
10.1016/S0344-0338(96)80123-3
Stereological evaluation of malignant mesothelioma versus benign pleural hyperplasia.
J. Bogers (1996)
10.1053/J.SEMDP.2006.06.005
Distinguishing benign mesothelial hyperplasia from neoplasia: a practical approach.
R. Kradin (2006)
10.1097/01.pas.0000165529.78945.dc
Localized Malignant Mesothelioma
T. Allen (2005)
10.1046/j.1365-2559.2002.01373.x
Malignant deciduoid mesothelioma of the pleura: report of two cases with long survival
G. Serio (2002)
10.1097/00000478-200002000-00015
Mesotheliomas with deciduoid morphology: a morphologic spectrum and a variant not confined to young females.
J. Shanks (2000)
United Kingdom Health and Safety Executive
(2006)
CD 99 ( p 30 ⁄ 32 MIC 2 ) Neuroectodermal ⁄ Ewing ’ s sarcoma antigen as an immunohistochemical marker : review of more than 600 tumors and the literature experience
AJ Stevenson (1994)
10.1038/modpathol.3800761
Detection of SS18-SSX fusion transcripts in formalin-fixed paraffin-embedded neoplasms: analysis of conventional RT-PCR, qRT-PCR and dual color FISH as diagnostic tools for synovial sarcoma
M. F. Amary (2007)
10.3109/01913128809064207
Lymphohistiocytoid mesothelioma: a rare lymphomatoid variant of predominantly sarcomatoid mesothelioma.
D. Henderson (1988)
10.1023/A:1008285708096
Pyothorax-associated lymphoma: description of the first two cases detected in Italy.
S. Ascani (1997)
10.1183/09031936.96.09091932
The epidemiology of mesothelioma in historical context.
J. C. Mcdonald (1996)
10.1046/j.1365-2559.2003.01674.x
‘Pseudomesotheliomatous’ carcinomas of the pleura: a 10‐year analysis of cases from the Environmental Lung Disease Research Group, Cardiff
R. Attanoos (2003)
10.1111/j.1365-2559.1995.tb01527.x
A comparative immunohistochemical study of malignant mesothelioma and renal cell carcinoma: the diagnostic utility of Leu‐M1, Ber EP4, Tamm‐Horsfall protein and thrombomodulin
R. Attanoos (1995)
10.1136/THORAX.55.10.860
Malignant vascular tumours of the pleura in "asbestos" workers and endothelial differentiation in malignant mesothelioma.
R. Attanoos (2000)
10.1046/j.1365-2559.2002.01422.x
Primary thymic epithelial tumours of the pleura mimicking malignant mesothelioma
R. Attanoos (2002)
10.1159/000093091
D2-40: A Reliable Marker in the Diagnosis of Pleural Mesothelioma
A. Müller (2006)
10.1016/S0046-8177(00)80194-X
Malignant epithelioid vascular tumors of the pleura: report of a series and literature review.
P. Zhang (2000)
10.1111/j.1440-1827.2007.02080.x
Immunohistochemical marker panels for distinguishing between epithelioid mesothelioma and lung adenocarcinoma
K. Kushitani (2007)
10.1097/01.pap.0000213064.05005.64
Applications and Limitations of Immunohistochemistry in the Diagnosis of Malignant Mesothelioma
S. Suster (2006)
10.1038/modpathol.3800259
Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma
Albert Y Chu (2005)
10.1038/modpathol.3800543
Mesothelioma with rhabdoid features: an ultrastructural and immunohistochemical study of 10 cases
N. Ordóñez (2006)
10.1002/DC.20208
The value of epithelial membrane antigen expression in separating benign mesothelial proliferation from malignant mesothelioma: A comparative study
R. Saad (2005)
Diagnosis of diffuse malignant mesothelioma: experience of a US/Canadian Mesothelioma Panel.
W. Mccaughey (1991)
10.1007/BF01600160
The influence of the diagnostic technique on the histopathological diagnosis in malignant mesothelioma
T. Gelder (2005)
10.1016/S0140-6736(95)90462-X
Continuing increase in mesothelioma mortality in Britain
J. Peto (1995)
10.1309/7ECY-KN61-PP1M-52EB
Lymphohistiocytoid mesothelioma. An often misdiagnosed variant of sarcomatoid malignant mesothelioma.
H. Khalidi (2000)
10.1038/sj.bjc.6602307
The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050
J. Hodgson (2005)
10.1016/S0140-6736(08)60727-8
Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial
M. Muers (2008)
10.1002/SSU.2980060510
Diagnosis and treatment of pleural mesothelioma.
V. Rusch (1990)
10.5555/URI:PII:074025709290008W
The concept of mesothelioma in situ: implications for diagnosis and histogenesis.
D. Whitaker (1992)
Detection of SS18SSX fusion transcripts in formalin-fixed paraffin-embedded neoplasms: analysis of conventional RT-PCR, qRT-PCR and dual color FISH as diagnostic tools for synovial sarcomas
MF Amary (2007)
10.1097/00000478-199610000-00007
Adenomatoid tumors of the pleura.
M. Kaplan (1996)
Neuroectodermal ⁄ Ewing’s sarcoma antigen as an immunohistochemical marker: review of more than 600 tumors and the literature experience
AJ Stevenson (1994)
10.1097/00000478-200604000-00006
h-Caldesmon, a Useful Positive Marker in the Diagnosis of Pleural Malignant Mesothelioma, Epithelioid Type
C. Comin (2006)
10.1016/J.CRAD.2005.05.015
Use of imaging in the management of malignant pleural mesothelioma.
R. Benamore (2005)
10.1053/J.SEMDP.2006.06.007
The role of immunohistochemistry in distinguishing squamous cell carcinoma from mesothelioma and adenocarcinoma in pleural effusion.
Q. Li (2006)
Novel marker D2-40, combined with calretinin, CEA, and TTF-1 : an optimal set of immunodiagnostic markers for pleural mesothelioma
三村 剛史 (2007)
10.1097/01.pap.0000213007.48479.94
Podoplanin: A Novel Diagnostic Immunohistochemical Marker
N. Ordóñez (2006)
10.1111/j.1365-2559.2007.02717.x
Pyothorax‐associated lymphoma: an unusual variant of an unusual tumour
E. Verghese (2007)
10.1007/s00428-005-0034-z
Pyothorax-associated lymphoma: an unusual case with both T- and B-cell genotypes
I. Nakamichi (2005)
10.1097/PAS.0b013e318033e7a8
h-Caldesmon, Calretinin, Estrogen Receptor, and Ber-EP4: A Useful Combination of Immunohistochemical Markers for Differentiating Epithelioid Peritoneal Mesothelioma From Serous Papillary Carcinoma of the Ovary
C. Comin (2007)
Angiosarcoma-like neoplasms of epithelial organs: true endothelial tumors or variants of carcinoma?
J. Ritter (1995)
10.1016/S0344-0338(97)80054-4
Malignant mesothelioma of the pleura. The reproducibility of the immunohistological diagnosis.
P. Betta (1997)
10.3109/01913129609016331
Mucin-positive epithelial mesotheliomas: a histochemical, immunohistochemical, and ultrastructural comparison with mucin-producing pulmonary adenocarcinomas.
S. Hammar (1996)
10.1111/j.1365-2559.2005.02331.x
Sensitivity and specificity of immunohistochemical markers used in the diagnosis of epithelioid mesothelioma: a detailed systematic analysis using published data
J. King (2006)
10.1080/0913120290104647
Deciduoid Mesothelioma: A Report of 5 Cases and Literature Review
J. Shia (2002)
10.1016/S0169-5002(00)00234-8
A left pleural effusion with a calcified tumoral mass and left hemithoracic uptake on bone scan.
É. Quoix (2001)
10.1586/14737159.5.5.715
Malignant mesothelioma: current status of histopathologic diagnosis and molecular profile
S. Suster (2005)
10.1097/00000478-200308000-00001
The Immunohistochemical Diagnosis of Mesothelioma: A Comparative Study of Epithelioid Mesothelioma and Lung Adenocarcinoma
N. Ordóñez (2003)
Lymphohistiocytoid mesothelioma: an often misdiagnosed variant of sarcomatoid mesothelioma
HS Khalidi (2000)
10.1016/J.HUMPATH.2005.01.019
D2-40 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma.
N. Ordóñez (2005)
10.1309/8FCHQ3VPBWM7B5X9
Immunohistochemical analysis of peritoneal mesothelioma and primary and secondary serous carcinoma of the peritoneum: antibodies to estrogen and progesterone receptors are useful.
R. Barnetson (2006)
10.1136/thx.43.5.366
Differentiation of malignant from normal and reactive mesothelial cells by the argyrophil technique for nucleolar organiser region associated proteins.
J. Ayres (1988)
10.1097/00000478-200311000-00003
Application of Mesothelin Immunostaining in Tumor Diagnosis
N. Ordóñez (2003)
Angiosarcoma of the pleura.
C. Pramesh (2004)
10.1038/modpathol.3800027
Diagnostic value of MUC4 immunostaining in distinguishing epithelial mesothelioma and lung adenocarcinoma
K. Llinares (2004)
10.1378/CHEST.123.2.551
Surgical treatment of malignant pleural mesothelioma: a review.
S. van Ruth (2003)
Mesothelioma mortality in Great Britain
DM McElvenny (1968)
10.3346/JKMS.2001.16.6.792
Epithelioid angiosarcoma of the pleura: a case report.
M. Roh (2001)
10.1043/1543-2165(2008)132[397:AOITTD]2.0.CO;2
Application of immunohistochemistry to the diagnosis of malignant mesothelioma.
A. Marchevsky (2008)
10.1046/j.1365-2559.2003.01686.x
The use of immunohistochemistry in distinguishing reactive from neoplastic mesothelium. A novel use for desmin and comparative evaluation with epithelial membrane antigen, p53, platelet‐derived growth factor‐receptor, P‐glycoprotein and Bcl‐2
R. Attanoos (2003)
10.1046/j.1365-2559.1998.00565.x
Synovial sarcoma of the pleura and its differentiation from other primary pleural tumours: a clinicopathological and immunohistochemical review of three cases
Nicholson (1998)
10.1177/107327480601300402
Malignant pleural mesothelioma: a comprehensive review.
R. Ismail-Khan (2006)
10.1046/j.1365-2559.2003.01628.x
Assessment of cell cycle state may facilitate the histopathological diagnosis of malignant mesothelioma
J. Sington (2003)
10.1097/00000478-200206000-00005
Pyothorax-Associated Lymphoma: A Peculiar Clinicopathologic Entity Derived From B Cells at Late Stage of Differentiation and With Occasional Aberrant Dual B- and T-Cell Phenotype
B. Petitjean (2002)
10.1007/s12199-007-0017-6
Pathology of mesothelioma
K. Inai (2008)
[Pleural malignant mesothelioma with osseous cartilaginous and rhabdomyogenic differentiation].
T. Okamoto (1998)
10.1097/01.MP.0000056981.16578.C3
Value of Mesothelin Immunostaining in the Diagnosis of Mesothelioma
N. Ordóñez (2003)
10.2486/INDHEALTH.45.379
Malignant mesothelioma: global incidence and relationship with asbestos.
C. Bianchi (2007)
10.1043/1543-2165(2005)129[1428:RAUOUP]2.0.CO;2
Review and update of uncommon primary pleural tumors: a practical approach to diagnosis.
L. Granville (2005)
10.1043/1543-2165(2006)130[823:EORCCM]2.0.CO;2
Expression of renal cell carcinoma-associated markers erythropoietin, CD10, and renal cell carcinoma marker in diffuse malignant mesothelioma and metastatic renal cell carcinoma.
K. Butnor (2006)
10.1046/j.1365-2559.2003.01685.x
Synchronous diffuse malignant mesothelioma and carcinomas in asbestos‐exposed individuals
R. Attanoos (2003)
10.1111/j.1365-2559.2006.02442.x
Sensitivity and specificity of immunohistochemical antibodies used to distinguish between benign and malignant pleural disease: a systematic review of published reports
J. King (2006)
10.1016/J.JTCVS.2006.09.050
Bone or pleura? Primary pleural osteosarcoma.
P. Chandak (2007)
10.1097/00000478-199405000-00002
Deciduoid Peritoneal Mesothelioma: An Unusual Phenotype Affecting Young Females
A. Nascimento (1994)
10.1136/jcp.45.4.295
Desmoplastic malignant mesothelioma: a review of 17 cases.
G. Wilson (1992)
10.1200/JCO.2002.09.021
Pyothorax-associated lymphoma: a review of 106 cases.
S. Nakatsuka (2002)



This paper is referenced by
10.5124/JKMA.2009.52.5.456
Pathological Diagnosis of Malignant Mesothelioma
Soon Hee Jung (2009)
10.1007/978-3-642-10862-4_5
Pathohistological diagnosis and differential diagnosis.
I. Tischoff (2011)
10.1038/onc.2017.147
E-cadherin expression is correlated with focal adhesion kinase inhibitor resistance in Merlin-negative malignant mesothelioma cells
T. Kato (2017)
10.1155/2019/8628612
MicroRNA Signatures in Malignant Pleural Mesothelioma Effusions
Kimberly A. Birnie (2019)
10.1016/j.pathol.2018.06.001
Pleural malignant mesothelioma versus pleuropulmonary synovial sarcoma: a clinicopathological study of 22 cases with molecular analysis and survival data.
S. Klebe (2018)
10.1097/COC.0b013e3181d31f02
Expert Opinions of the First Italian Consensus Conference on the Management of Malignant Pleural Mesothelioma
C. Pinto (2011)
10.1007/s11255-019-02153-x
Florid mesothelial hyperplasia of the tunica vaginalis: report of two cases with immunohistochemical findings
D. Athanazio (2019)
Practical approaches to diagnose and treat for T0 malignant pleural mesothelioma: a proposal for diagnostic total parietal pleurectomy
Seiki HasegawaNobuyuki (2012)
10.1016/B978-0-7020-4226-3.00022-6
Transmission electron microscopy
Anthony E. Woods (2013)
10.1177/030089161109700204
Malignant Mesothelioma of the Pleura in Nonagenarian Patients
Claudio Bianchi (2011)
10.1097/JTO.0b013e3181f1cf2b
Malignant Pleural Mesothelioma: A Population-Based Study of Survival
M. Milano (2010)
10.1002/ijc.25285
Downregulated microRNAs in the differential diagnosis of malignant pleural mesothelioma
G. V. Gee (2010)
10.3892/OL.2015.3652
DNA copy number gains in malignant pleural mesothelioma.
M. Furukawa (2015)
10.3748/WJG.15.4856
Malignant mesothelioma of the greater omentum mimicking omental infarction: a case report.
Min-Kee Shin (2009)
10.1007/s10147-011-0368-2
Practical approaches to diagnose and treat for T0 malignant pleural mesothelioma: a proposal for diagnostic total parietal pleurectomy
S. Hasegawa (2011)
Artigo de Revisão Review Article
Lina Carvalho (2009)
10.14670/HH-28.663
Immunohistochemistry of cytokeratins 7, 8, 17, 18, and 19, and GLUT-1 aids differentiation of desmoplastic malignant mesothelioma from fibrous pleuritis.
T. Horiuchi (2013)
10.5606/tgkdc.dergisi.2016.11606
Epithelial membrane antigen in differential diagnosis of malignant mesothelioma, metastatic adenocarcinoma, and reactive mesothelial hyperplasia Malign mezotelyoma, metastatik adenokarsinoma ve reaktif mezotelyal hiperplazi ayirici tanisinda epitelyal membran antijeni
Sibel Arslan (2016)
10.1155/2014/413946
Pleural Fluid Mesothelin as an Adjunct to the Diagnosis of Pleural Malignant Mesothelioma
J. Creaney (2014)
10.1007/s00104-013-2518-8
Regionale Versorgung des malignen Pleuramesothelioms
M. Ried (2013)
10.1700/667.7776
Malignant mesothelioma of the pleura in nonagenarian patients.
C. Bianchi (2011)
10.1007/s10147-011-0369-1
Pathological and molecular biological approaches to early mesothelioma
T. Tsujimura (2011)
10.1111/j.1365-2303.2010.00829.x
The diagnostic and molecular characteristics of malignant mesothelioma and ovarian/peritoneal serous carcinoma
B. Davidson (2011)
10.4132/KoreanJPathol.2014.48.2.91
Pleural Mesothelioma: An Institutional Experience of 66 Cases
Soomin Ahn (2014)
10.1007/s10405-009-0350-0
Therapie des malignen Pleuramesothelioms
Hanno Huwer (2009)
10.1164/rccm.200907-1020OC
Diagnostic performance of soluble mesothelin and megakaryocyte potentiating factor in mesothelioma.
K. Hollevoet (2010)
10.5795/JJSCC.50.226
頭部皮膚転移が診断の契機となった肉腫型胸膜悪性中皮腫の 1 例
希 高畠 (2011)
10.1007/s00063-009-1162-z
Versicherungsmedizinische Aspekte bei peritonealen Mesotheliomen und sonstigen peritonealen Tumoren
Volker Neumann (2009)
10.5530/JCDR.2014.4.11
Case of Primary Pericardial Mesothelioma
Syed Ali (2014)
10.4172/2167-7719.1000E121
Asbestos Risks: Past and Present
Joyce K. Thompson (2013)
10.12659/MSM.890020
Malignant pleural mesothelioma: A single-center experience in Turkey
A. Sezer (2014)
10.1136/thoraxjnl-2014-205205
Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma
J. Creaney (2014)
See more
Semantic Scholar Logo Some data provided by SemanticScholar